HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 18 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $5,000 | -83.3% | 16,054 | -64.3% | 0.00% | – |
Q3 2019 | $30,000 | -66.7% | 44,914 | -17.4% | 0.00% | – |
Q2 2019 | $90,000 | +5.9% | 54,369 | +60.8% | 0.00% | – |
Q1 2019 | $85,000 | -43.7% | 33,810 | -43.0% | 0.00% | – |
Q4 2018 | $151,000 | -41.2% | 59,340 | -24.6% | 0.00% | – |
Q2 2018 | $257,000 | +424.5% | 78,701 | +172.2% | 0.00% | – |
Q3 2017 | $49,000 | – | 28,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
Virtu Financial LLC | 12,049 | $4,000 | 0.00% |